NCT04192045

Brief Summary

Quality of recovery is an important outcome measure in anaesthesia, whilst there are validated tools for this in surgery and regional anesthesia there are no fully validated tools for obstetrics anaesthesia. The aim of this study is to use the Obstetric Quality of Recovery (ObsQoR) score across multiple centres to assess correlation to length of stay and variation for different types of operative and non- operative delivery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,638

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 10, 2019

Completed
1.8 years until next milestone

Study Start

First participant enrolled

October 11, 2021

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 24, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 24, 2021

Completed
Last Updated

June 15, 2022

Status Verified

June 1, 2022

Enrollment Period

13 days

First QC Date

November 8, 2019

Last Update Submit

June 14, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • • Correlation of ObsQoR with length of hospital stay (LOS) in hours following delivery across multiple centres, particularly ObsQoR score and prediction of prolonged LOS (>1.5 SD) and readmission to hospital.

    During the study the total length of stay in hours will be calculated for participating patients. This will be correlated with the score from the ObsQoR survey tool. In addition the readmission status of the patient will be asked at the subsequent survey combined with the patient's health care record to correlate with the ObsQoR tool score. Where the ObsQoR score is measured between 0-100 and LOS will be in hours. Readmission will be a binary outcome measure

    Up to 3 months

  • • The relationship between ObsQoR and patient-reported ready for discharge. This will concurrently be determined to account for institutional, non-medical maternal factors neonatal factors that may delay discharge and impact LOS.

    The patient will be surveyed using the ObsQoR tool and also asked regarding when they felt they were ready for discharge to take into account the multitude of factors which may impact on the overall length of stay. Where the ObsQoR score is measured between 0-100 and LOS will be in hours.

    up to 3 months

Secondary Outcomes (14)

  • • Comparing ObsQoR profiles with differing types of obstetric anaesthesia and delivery method.

    up to 3 months

  • • Variations in ObsQoR scores across differing centres.

    up to 3 months

  • • Impact of patient factors on ObsQoR score.

    up to 3 months

  • • Impact of anaesthetic or obstetric factors on ObsQoR score.

    up to 3 months

  • • Impact of neonatal facts on ObsQoR score.

    up to 3 months

  • +9 more secondary outcomes

Interventions

SurveyOTHER

A survey will be used at 24 hours and 30 days to assess the quality of recovery

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale peripartum
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Peripartum women during the designated study period who have received anaesthetic intervention in the previous 24-hour period for 3 consecutive days.

You may qualify if:

  • Obstetric patients over 18 years old.
  • Intervention occurring after 32/40 gestation.
  • All mothers receiving anaesthesia or anaesthetic analgesia during their peripartum period.

You may not qualify if:

  • Unable to comprehend the questions asked
  • Patient refusal
  • Under 32/40 weeks gestation
  • Cervical cerclage insertion or removal, anaesthesia for External Cephalic Verison
  • Neonatal death
  • Non- NHS patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guy's and St Thomas' NHS Foundation Trust

London, SE1 7RT, United Kingdom

Location

Biospecimen

Retention: SAMPLES WITH DNA

Samples will be taken from selected Caesarean Delivery Patients before and after delivery to analyse to assess immune profiles.

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Kariem El-Boghdadly

    GSTT

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 8, 2019

First Posted

December 10, 2019

Study Start

October 11, 2021

Primary Completion

October 24, 2021

Study Completion

November 24, 2021

Last Updated

June 15, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

The raw data will be available on request at the discretion of the central study team

Locations